Real-World Treatment Patterns and Clinical Outcomes in Patients With Multiple Myeloma Previously Treated With Lenalidomide and an Anti-CD38 Monoclonal Antibody
There is no uniform standard of care for patients with RRMM with prior exposure to lenalidomide and anti-CD38 mAbs. Survival outcomes are poor, with a need for effective treatments for these patients.
Authors
- Edward Yu
- Susan Fish
- Amol D. Dhamane
- Brian G.M. Durie (ORCID: https://orcid.org/0000-0002-9883-3769)
- Ravi Vij (ORCID: https://orcid.org/0000-0001-8795-3610)
- Sundar Jagannath (ORCID: https://orcid.org/0000-0003-2934-6518)
- David F Cella (ORCID: https://orcid.org/0000-0002-9881-4541)
- Robert M. Rifkin (ORCID: https://orcid.org/0000-0003-3141-1518)
- Sikander Ailawadhi (ORCID: https://orcid.org/0000-0002-8377-8111)
- Rafat Abonour (ORCID: https://orcid.org/0000-0003-1491-2548)
- Hans Chulhee Lee (ORCID: https://orcid.org/0000-0001-8545-3292)
- Karthik Ramasamy (ORCID: https://orcid.org/0000-0003-3385-3707)
- Carrie Ho (ORCID: https://orcid.org/0000-0003-4437-9377)
- Sujith Dhanasiri
- Liang Liu (ORCID: https://orcid.org/0000-0003-1372-4596)
- Tao Gu (ORCID: https://orcid.org/0000-0002-3110-2152)
- Andrew J. Cowan
- David J. Kuter (ORCID: https://orcid.org/0000-0002-7855-2409)
- Thomas S. Marshall
- Jiaqi Fang
- Jessica Katz
- Amir Samuel
Institutions
- Cedars-Sinai Medical Center (US)
- The University of Texas MD Anderson Cancer Center (US)
- Harvard University (US)
- Washington University in St. Louis (US)
- Oxford Health NHS Foundation Trust (GB)
- Massachusetts General Hospital (US)
- Fred Hutch Cancer Center (US)
- Bristol-Myers Squibb (United States) (US)
- Rocky Mountain Cancer Centers (US)
- Mayo Clinic in Florida (US)
- Oxford University Hospitals NHS Trust (GB)
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University
- Indiana University School of Medicine
- Bristol-Myers Squibb (Switzerland) (CH)
- Indiana University – Purdue University Indianapolis (US)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- Clinical Lymphoma Myeloma & Leukemia
- Published
- 2024-12-07
- DOI
- https://doi.org/10.1016/j.clml.2024.12.002
- Citations
- 8
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 3.64
Funders
- Bristol-Myers Squibb